Detailansicht

Wissensnetz

Person

Stefan A. Körber

Arzt

Name	Stefan A. Körber
Ort	Regensburg (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	S. A. Körber S. A. Koerber Stefan Alexander Körber Stefan Körber Stefan Alexander Koerber Stefan A. Koerber
Weitere Angaben	Assistenzarzt an der Radiologischen Klinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	1023031140
Datensatz-ID	1023031140
Beteiligt an alle anzeigen The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO) The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO) European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy European Association of Urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story? : : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients 68Ga-FAPI-PET/CT in patients with various gynecological malignancies Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer Moderne Bestrahlungsplanung und bildgeführte Strahlentherapie am Beispiel des Prostatakarzinoms Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419) Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity Bedeutung und Nutzen von PSMA-Liganden beim Prostatakarzinom Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison Postoperative radiotherapy of patients with thymic epithelial tumors (TET) : A retrospective analysis of outcome and toxicity Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis Generierung von Antikörperfragmenten gegen Prostatakrebszellen mittels der Phage-Display-Technologie

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Stefan A. Körber

The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)

The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)

European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy

European Association of Urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology

Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story? : : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT

Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

Moderne Bestrahlungsplanung und bildgeführte Strahlentherapie am Beispiel des Prostatakarzinoms

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients

First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial

Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial

Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients

Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure

Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity

Bedeutung und Nutzen von PSMA-Liganden beim Prostatakarzinom

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison

Postoperative radiotherapy of patients with thymic epithelial tumors (TET) : A retrospective analysis of outcome and toxicity

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis

Generierung von Antikörperfragmenten gegen Prostatakrebszellen mittels der Phage-Display-Technologie